Guangdong Sunshine Pharmaceutical Co Ltd – FDA Inspection, Apr 18, 2025

Record Details

This FDA Inspection record concerns Guangdong Sunshine Pharmaceutical Co Ltd, with an inspection on April 18, 2025, issued by the Office of Inspections and Investigations, covering human drugs.

Company: Guangdong Sunshine Pharmaceutical Co Ltd
Inspection Date: April 18, 2025
Product Type: Human Drugs
Office: Office of Inspections and Investigations
Person: Patty P. Kaewussdangkul (FDA Associated Person)

View Company Profile

ID · d49fc0bd-9726-4b60-b47a-44b14a7faf57

Inspection Facts

Inspection number: 1270353
FDA center: Human Drugs
Outcome: Form 483 issued, view the record

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Guangdong Sunshine Pharmaceutical Co Ltd

FDA Inspection

Guangdong Sunshine Pharmaceutical Co LtdApril 18, 2025

Guangdong Sunshine Pharmaceutical Co Ltd – FDA Inspection, Apr 18, 2025

Record Details

This FDA Inspection record concerns Guangdong Sunshine Pharmaceutical Co Ltd, with an inspection on April 18, 2025, issued by the Office of Inspections and Investigations, covering human drugs.